 <h1>Nucynta ER Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>tapentadol</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about tapentadol. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Nucynta ER.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to tapentadol: oral tablet, oral tablet extended release</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet; Tablet, Extended Release)</p><p>Tapentadol oral tablets or extended-release tablets expose users to risks of addiction, abuse, and misuse, which can lead to overdose and death. Assess patientâ€™s risk before prescribing and monitor regularly for these behaviors and conditions.</p><p>:To ensure that the benefits of opioid analgesics outweigh the risks of addiction, abuse, and misuse, the Food and Drug Administration (FDA) has required a Risk Evaluation and Mitigation Strategy (REMS) for these products.</p><p>Serious, life-threatening, or fatal respiratory depression may occur. Monitor closely, especially upon initiation or following a dose increase.</p><p>Accidental ingestion of tapentadol oral tablets or extended-release tablets, especially by children, can result in a fatal overdose of tapentadol.Neonatal Opioid Withdrawal SyndromeProlonged use of tapentadol oral tablets or extended-release tablets during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated. If prolonged opioid use is required in a pregnant woman, advise the patient of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available.</p><p>Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing for use in patients for whom alternative treatment options are inadequate; limit dosages and durations to the minimum required; and follow patients for signs and symptoms of respiratory depression and sedation.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, tapentadol (the active ingredient contained in Nucynta ER) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking tapentadol:</p><p>
<i>Less common</i>
</p><ul>
<li>Bladder pain</li>
<li>bloody or cloudy urine</li>
<li>body aches or pain</li>
<li>chills</li>
<li>cough</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty with breathing</li>
<li>fever</li>
<li>headache</li>
<li>loss of voice</li>
<li>lower back or side pain</li>
<li>muscle aches</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Anxiety</li>
<li>being forgetful or confused</li>
<li>clumsiness or unsteadiness</li>
<li>drowsiness</li>
<li>fast or irregular heartbeat</li>
<li>feeling drunk</li>
<li>irritability or restlessness</li>
<li>joint pain, stiffness, or swelling</li>
<li>pale or blue lips, fingernails, or skin</li>
<li>rash, hives, or itching</li>
<li>seizures</li>
<li>sensation of heaviness</li>
<li>shakiness or trembling</li>
<li>slurred speech</li>
<li>swelling of the eyelids, face, lips, hands, or feet</li>
<li>tightness in the chest</li>
<li>trouble with speaking or hoarseness</li>
<li>troubled swallowing</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>changes in behavior</li>
<li>confusion</li>
<li>darkening of the skin</li>
<li>diarrhea</li>
<li>dizziness</li>
<li>fainting</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>loss of appetite</li>
<li>mental depression</li>
<li>nausea</li>
<li>overactive reflexes</li>
<li>poor coordination</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>shivering</li>
<li>sweating</li>
<li>talking or acting with excitement you cannot control</li>
<li>thoughts of killing oneself</li>
<li>trembling or shaking</li>
<li>twitching</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of tapentadol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Constipation</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abnormal dreams</li>
<li>heartburn or indigestion</li>
<li>muscle pain or stiffness</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>stomach discomfort, upset, or pain</li>
<li>unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Change in vision</li>
</ul><p>
<!-- end oral tablet, oral tablet extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tapentadol: oral tablet, oral tablet extended release</i></p><h3>General</h3><p>The most common adverse reactions were nausea, dizziness, vomiting, constipation, headache, and somnolence.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 30%), vomiting (up to 18%), constipation (up to 17%)</p>
<p><b>Common</b> (1% to 10%): Dry mouth, dyspepsia, diarrhea, abdominal discomfort</p>
<p><b>Rare</b> (less than 0.1%): Impaired gastric emptying<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 24%), headache (up to 15%), somnolence (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Tremor, lethargy, vertigo, disturbance in attention, sedation, hypoesthesia</p>
<p><b>Uncommon</b> (0.1% to 1%): Memory impairment, mental impairment, syncope, balance disorder, dysarthria, paresthesia, depressed level of consciousness, presyncope, ataxia</p>
<p><b>Rare</b> (less than 0.1%): Convulsion, coordination abnormal</p>
<p><b>Frequency not reported</b>: Seizure, serotonin syndrome<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, confusion, abnormal dreams, anxiety, depression, irritability, nervousness, drug withdrawal syndrome, restlessness, sleep disorder, hallucination, depressed mood</p>
<p><b>Uncommon</b> (0.1% to 1%): Disorientation, agitation, perception disturbances, euphoric mood, nightmare</p>
<p><b>Rare</b> (less than 0.1%): Thinking abnormal, drug dependence</p>
<p><b>Postmarketing reports</b>: Suicidal ideation, panic attack<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, asthenia, chills, edema, feeling hot, feeling cold, feeling of body temperature change, mucosal dryness</p>
<p><b>Uncommon</b> (0.1% to 1%): Feeling abnormal, feeling drunk, feeling of relaxation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, hyperhidrosis, pruritus generalized, rash, flushing</p>
<p><b>Uncommon</b> (0.1% to 1%): Urticaria</p>
<p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasopharyngitis, upper respiratory tract infection, dyspnea</p>
<p><b>Uncommon</b> (0.1% to 1%): Respiratory depression, oxygen saturation decreased, cough<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hot flush, hypotension</p>
<p><b>Uncommon</b> (0.1% to 1%): Heart rate increased, heart rate decreased, blood pressure decreased, palpitations, left bundle branch block<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, erectile dysfunction</p>
<p><b>Uncommon</b> (0.1% to 1%): Urinary hesitation, pollakiuria, sexual dysfunction<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia, involuntary muscle contractions, muscle spasms</p>
<p><b>Uncommon</b> (0.1% to 1%): Bone pain, sensation of heaviness<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite</p>
<p><b>Uncommon</b> (0.1% to 1%): Weight decreased<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Vision blurred</p>
<p><b>Uncommon</b> (0.1% to 1%): Visual disturbance<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity</p>
<p><b>Postmarketing reports</b>: Anaphylaxis, anaphylactic shock<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): GGT increased, ALT increased, AST increased<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Nucynta (tapentadol)." PriCara Pharmaceuticals, Raritan, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Nucynta ER (tapentadol)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En EspaÃ±ol</li>
<li>76 Reviews</li>
<li>Drug class: narcotic analgesics</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nucynta ER &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Nucynta</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Diabetic Peripheral Neuropathy</li>
<li>Pain</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tapentadol: oral tablet, oral tablet extended release</i></p><h3>General</h3><p>The most common adverse reactions were nausea, dizziness, vomiting, constipation, headache, and somnolence.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 30%), vomiting (up to 18%), constipation (up to 17%)</p><p><b>Common</b> (1% to 10%): Dry mouth, dyspepsia, diarrhea, abdominal discomfort</p><p><b>Rare</b> (less than 0.1%): Impaired gastric emptying<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 24%), headache (up to 15%), somnolence (up to 15%)</p><p><b>Common</b> (1% to 10%): Tremor, lethargy, vertigo, disturbance in attention, sedation, hypoesthesia</p><p><b>Uncommon</b> (0.1% to 1%): Memory impairment, mental impairment, syncope, balance disorder, dysarthria, paresthesia, depressed level of consciousness, presyncope, ataxia</p><p><b>Rare</b> (less than 0.1%): Convulsion, coordination abnormal</p><p><b>Frequency not reported</b>: Seizure, serotonin syndrome<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, confusion, abnormal dreams, anxiety, depression, irritability, nervousness, drug withdrawal syndrome, restlessness, sleep disorder, hallucination, depressed mood</p><p><b>Uncommon</b> (0.1% to 1%): Disorientation, agitation, perception disturbances, euphoric mood, nightmare</p><p><b>Rare</b> (less than 0.1%): Thinking abnormal, drug dependence</p><p><b>Postmarketing reports</b>: Suicidal ideation, panic attack<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, asthenia, chills, edema, feeling hot, feeling cold, feeling of body temperature change, mucosal dryness</p><p><b>Uncommon</b> (0.1% to 1%): Feeling abnormal, feeling drunk, feeling of relaxation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, hyperhidrosis, pruritus generalized, rash, flushing</p><p><b>Uncommon</b> (0.1% to 1%): Urticaria</p><p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasopharyngitis, upper respiratory tract infection, dyspnea</p><p><b>Uncommon</b> (0.1% to 1%): Respiratory depression, oxygen saturation decreased, cough<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hot flush, hypotension</p><p><b>Uncommon</b> (0.1% to 1%): Heart rate increased, heart rate decreased, blood pressure decreased, palpitations, left bundle branch block<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, erectile dysfunction</p><p><b>Uncommon</b> (0.1% to 1%): Urinary hesitation, pollakiuria, sexual dysfunction<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia, involuntary muscle contractions, muscle spasms</p><p><b>Uncommon</b> (0.1% to 1%): Bone pain, sensation of heaviness<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite</p><p><b>Uncommon</b> (0.1% to 1%): Weight decreased<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Vision blurred</p><p><b>Uncommon</b> (0.1% to 1%): Visual disturbance<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity</p><p><b>Postmarketing reports</b>: Anaphylaxis, anaphylactic shock<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): GGT increased, ALT increased, AST increased<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Nucynta (tapentadol)." PriCara Pharmaceuticals, Raritan, NJ. </p><h2>More about Nucynta ER (tapentadol)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En EspaÃ±ol</li>
<li>76 Reviews</li>
<li>Drug class: narcotic analgesics</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nucynta ER &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Nucynta</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Diabetic Peripheral Neuropathy</li>
<li>Pain</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>